71860-102-01 : NDC 2026 Code

71860-102-01 : Olezarsen Sodium ( Tryngolza )

Additionally :

You can get information about “71860-102-01” NDC code in 71860-102-01 in HTML format

HTML | 71860-102-01 in TXT (Plain Text) format

TXT | 71860-102-01 in PDF (Portable Document Format)

PDF | 71860-102-01 in XML format

XML formats.

NDC Code : 71860-102-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "71860-102-01",
    "PackageDescription": "1 SYRINGE, GLASS in 1 CARTON (71860-102-01)  / .8 mL in 1 SYRINGE, GLASS",
    "NDC11Code": "71860-0102-01",
    "ProductNDC": "71860-102",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Tryngolza",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Olezarsen Sodium",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20260624",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA218614",
    "LabelerName": "Ionis Pharmaceuticals, Inc.",
    "SubstanceName": "OLEZARSEN SODIUM",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/.8mL",
    "Pharm_Classes": "APOC-III-directed RNA Interaction [EPC], Antisense Oligonucleotide [EPC], Antisense [CS], Increased RNA Degradation [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-07-06",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260624",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}